MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neurobehavioral disorders"

  • 2019 International Congress

    Grey-matter volume changes underpinning irritability and aggression in early manifest Huntington’s disease

    S. Martinez-Horta, F. Sampedro, J. Perez-Perez, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore grey-matter volume (GMV) differences between early-stage Huntington's disease (HD) patients with and without significant irritability/aggression symptoms (IAs) and to assess it association…
  • 2019 International Congress

    Clinical and cognitive features of anxiety in Parkinson’s disease

    G. Carey, L. Defebvre, A. Moonen, A. Leentjens, K. Dujardin (Lille, France)

    Objective: To determine the demographic, clinical and cognitive features associated with anxiety disorders in Parkinson’s disease (PD). Background: The point prevalence of anxiety disorders in…
  • 2019 International Congress

    Progression of neuropsychiatric symptoms in Parkinson’s disease

    J. Dlay, G. Duncan, T. Khoo, C. Williams-Gray, D. Breen, R. Barker, D. Burn, R. Lawson, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

    Objective: To determine the progression of neuropsychiatric symptoms (NPS) in Parkinson’s disease (PD) and their associations with quality of life (QoL) and motor problems. Background:…
  • 2019 International Congress

    Defence Mechanism of Ego and Coping Strategy Style of the Patient with Parkinson’s Disease

    M. Kulsum, S. Choudhury, A. Ghosh, P. Ghosh (Kolkata, India)

    Objective: To find out the prevalence of different defence mechanism and coping strategies in the patients with PD.To find out the relationship between using of…
  • 2019 International Congress

    Dopamine agonist withdrawal syndrome in Sardinian patients affected by Parkinson’s disease

    P. Paolo, R. Pau, G. Orofino, T. Ercoli, F. Marrosu, G. Defazio (Monserrato, Italy)

    Objective: The aims of this study was to determine the frequency of Dopamine agonist (DA) withdrawal syndrome (DAWS) in a sample of Sardinian patients with…
  • 2019 International Congress

    Expanding the Phenotype of KCNA2 Mutation: Tics and Stereotypies

    J. Legacy, M. Burns, A. Elkouzi, W. Deeb, I. Malaty (Gainesville, FL, USA)

    Objective: To report a case of KCNA2 mutation variant with tics. Background: Mutations in the KCNA2 gene impact the function of a voltage-gated potassium channel…
  • 2019 International Congress

    Case report: Chorea-acynthocytosis with two compoud heterozygous VPS13A large deletions

    D. Spieler, A. Mühlbäck, A. Velayos-Baeza, F. Castrop, C. Maegerlein, J. Slotta-Hispenina, B. Bader, B. Haslinger, J. Klempir, A. Danek (Freiburg, Germany)

    Objective: We report a 33 year old male patient without functional protein due to compound heterozygosity for VPS13A deletions and discuss the molecular diagnostic difficulties…
  • 2019 International Congress

    The Impact of Tourette Syndrome and Tic Disorders on Education, Occupational and Personal Life

    I. Malaty, D. Shineman, W. Deeb (Gainesville, FL, USA)

    Objective: To explore the impact of tic disorders on life outcomes in a “real world” sample of Tourette syndrome (TS) and tic disorder (TD) sufferers.…
  • 2019 International Congress

    Diagnosis and Treatment Experiences in a Real-World Sample of Tourette Syndrome and Tic Disorder Sufferers

    I. Malaty, D. Shineman, W. Deeb (Gainesville, FL, USA)

    Objective: To explore diagnosis and treatment experiences in a “real world” sample of Tourette syndrome and tic disorders. Background: Tourette syndrome (TS) is a complex,…
  • 2019 International Congress

    Association of alexithymia and Parkinson’s Disease (PD) in Mexican population

    L. Zuazua, M. Rodriguez, A. Cervantes, A. Balderas, R. Cruz, A. Alcocer, A. Perez, O. Esquivel, L. Navarro (Mexico City, Mexico)

    Objective: To identify the frequency of alexithymia in a Mexican sample of persons with Parkinson's disease Background: Alexithymia is related to a cognitive-affective alteration, characterized…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley